EXTON, PA — West Pharmaceutical Services, Inc. (NYSE: WST), a leading manufacturer of healthcare products, has announced plans to release its fourth-quarter and full-year financial results for 2023 ahead of the market opening on Thursday, February 15, 2024. The company will subsequently host a conference call at 9:00 a.m. Eastern Time to discuss these results and outline business expectations.
Investors, analysts, and other interested parties are invited to listen to the live audio-only webcast of the conference call, which will be available on the company’s Investor Relations website. For those wishing to actively participate in the conference call and pose questions to management, registration is required in advance. Once registered, participants will receive a unique PIN number and a dial-in number to access the call.
In addition to discussing the financial results, the management team will also refer to a slide presentation during the call. This presentation will be made available on the day of the call under the “Presentations” section in the “Investors” area of the company’s website.
For those unable to attend the live conference call, a replay will be available on the company’s website for 30 days after the event. Additionally, a live audio webcast of the conference call will be accessible in the “Investors” section of the company’s website, with replays available for approximately 90 days following the event.
The upcoming conference call is expected to provide valuable information about the company’s current financial position and future business expectations.
For the latest news on everything happening in Chester County and the surrounding area, be sure to follow MyChesCo on Google News and MSN.